Australia Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Marijuana, Hemp), By Derivative (CBD, THC), By End-use (Medical, Recreational, Industrial), And Segment Forecasts, 2025 - 2030

Australia Legal Cannabis Market Growth & Trends

The Australia legal cannabis market size is expected to reach USD 540.6 million by 2030, registering a CAGR of 23.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Factors such as a growing patient population, cannabis legalization, government initiatives, and the presence of local and foreign players in the country contribute to market growth. For instance, according to the data published by the Penington Institute in 2022, approximately 250,000 medicinal cannabis prescriptions were approved up to June 2022.

The marijuana industry is booming due to the increasing adoption of marijuana for medical and adult use. Marijuana has only been legalized for medical use in Australia and is anticipated to be legalized for recreational use as well. Through these legalizations, the government can try to curb the illicit marijuana market and focus on gaining substantial revenue from taxes levied on cannabis products. Moreover, the legalization and adoption of cannabis and the launch of new cannabis products are anticipated to increase market growth. For instance, in September 2023, MediPharm Labs Corp., a pharmaceutical company, launched new GMP cannabis products, such as Beacon inhalation cartridges and medical cannabis oil, in the Australian healthcare market.

The number of patients seeking medical marijuana for therapeutic benefits has increased. Moreover, the number of companies operating in the medical marijuana market is growing. Many companies have also been listed on the Australian Stock Exchange (ASX). As the market evolves, small local players and entrepreneurs increase in the Australian legal cannabis market. These players apply for cultivation licenses and are being funded or acquired by major players. For instance, in October 2023, Vitura Health Limited, a provider of medicinal cannabis products and digital health solutions, acquired Doctors On Demand, a telehealth service company, to enter new service and product verticals.

Moreover, growing awareness among people regarding the therapeutic applications of cannabis and the launch of new cannabis-based products drive market growth. For instance, according to data published by the Penington Institute in 2022, TGA has given 70,000 medicinal cannabis approvals for chronic pain in 2021. Moreover, medicinal cannabis is approved for sleep issues, anxiety, and cancer pain.

Australia Legal Cannabis Market Report Highlights

  • The hemp segment dominated the market for legal cannabis in Australia and accounted for the highest revenue share of 67.1% in 2024. The marijuana segment is expected to grow at the fastest CAGR during the forecast period.
  • The CBD segment held the largest market share of 63.5% in 2024. The THC segment is expected to grow at a lucrative CAGR during the forecast period.
  • The industrial application segment dominated the Australia legal cannabis market and accounted for the largest revenue share of 63.6% in 2024. The recreational segment is expected to grow at the fastest CAGR during the forecast period.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Source outlook
2.2.2. Derivative outlook
2.2.3. End use outlook
2.3. Competitive Insights
Chapter 3. Australia Legal Cannabis Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Parent Market Outlook
3.3. Ancillary Market Outlook
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.2. Market restraint analysis
3.5. Australia Legal Cannabis Market Analysis Tools
3.5.1. Industry Analysis - Porter’s Five Forces Analysis
3.5.2. PESTEL Analysis
3.6. Market Trends in the Country
3.6.1. Introduction of New Cannabis Products
3.6.2. Celebrity Cannabis Engagement
3.6.3. Growing Popularity of Craft and Boutique Cannabis Brands
3.6.4. Improved Cannabis Cultivation and Distribution Technology
3.6.5. Federal and State Cannabis Policy Opportunities
3.7. Regulatory Scenario in Australia
3.8. Jurisdiction Analysis in Australia
3.9. Cannabis Consumption Pattern Analysis, Australia
3.10. Legal Cannabis Potential Trade Opportunity, Australia
3.10.1. Global Legal Marijuana Trade Route
3.10.2. Global Hemp Trade Route
3.11. Legal Cannabis Seed to Shelf Story
3.11.1. Section Description
3.11.2. Cultivators & Growers
3.11.3. Manufacturers & Producers
3.11.4. Testers
3.11.5. Wholesalers & Distributors
3.11.6. Retailers
3.11.7. Supply Chain Analysis
3.11.8. Supply Chain Network from Hemp Cultivators to CBD Consumer Products
3.11.9. Supply Chain Network of Hemp Biomass to Industrial Applications
3.11.10. Supply Chain Network from Marijuana Plants to Marijuana Oil
3.12. Profit Margin Analysis
Chapter 4. Australia Legal Cannabis Market: Source Estimates & Trend Analysis
4.1. Definitions and Scope
4.2. Source Segment Dashboard
4.3. Australia Legal Cannabis Market by Source, 2018 to 2030
4.4. Marijuana
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.2. Flower
4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.3. Oil and Tinctures
4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Hemp
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Hemp CBD
4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Supplements
4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Industrial Hemp
4.5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Australia Legal Cannabis Market: Derivative Estimates & Trend Analysis
5.1. Definitions and Scope
5.2. Derivative Segment Dashboard
5.3. Australia Legal Cannabis Market by Derivative, 2018 to 2030
5.4. CBD
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. THC
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Australia Legal Cannabis Market: End Use Estimates & Trend Analysis
6.1. Definitions and Scope
6.2. End Use Segment Dashboard
6.3. Australia Legal Cannabis Market by End Use, 2018 to 2030
6.4. Medical
6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.2. Cancer
6.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.3. Chronic Pain
6.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.4. Depression and Anxiety
6.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.5. Arthritis
6.4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.6. Diabetes
6.4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.7. Glaucoma
6.4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.8. Migraines
6.4.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.9. Epilepsy
6.4.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.10. Multiple Sclerosis
6.4.10.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.11. AIDS
6.4.11.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.12. Amyotrophic Lateral Sclerosis
6.4.12.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.13. Alzheimer’s Disease
6.4.13.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.14. Post Traumatic Stress Disorder (PTSD)
6.4.14.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.15. Parkinson's Disease
6.4.15.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.16. Tourette
6.4.16.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.17. Others
6.4.17.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5. Recreational
6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.6. Industrial
6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Company Market Position Analysis
7.4. Company Profiles
7.4.1. Cann Group Limited
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Zelira Therapeutics
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. AusCann Group Holdings Ltd.
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Bod Australia
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Althea Group
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. ECOFIBRE
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Botanix Pharmaceuticals
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. EPSILON
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Little Green Pharma
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Incannex
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings